{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T21:03:13Z","timestamp":1794344593249,"version":"4.9.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01-AI145435-A1"],"award-info":[{"award-number":["R01-AI145435-A1"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01-AI153349"],"award-info":[{"award-number":["R01-AI153349"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R56-AI179012-A1"],"award-info":[{"award-number":["R56-AI179012-A1"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01-AI190038"],"award-info":[{"award-number":["R01-AI190038"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000052","name":"U.S. Department of Health & Human Services | NIH | NIH Office of the Director","doi-asserted-by":"publisher","award":["S10-OD030381-A1"],"award-info":[{"award-number":["S10-OD030381-A1"]}],"id":[{"id":"10.13039\/100000052","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-75202-6","type":"journal-article","created":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T09:03:23Z","timestamp":1784624603000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Host-directed treatments for tuberculous meningitis utilizing a multi-platform approach across mouse and human models"],"prefix":"10.1038","volume":"17","author":[{"given":"Carlos E.","family":"Ruiz-Gonzalez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Medha","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuderleys","family":"Masias-Leon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1574-7759","authenticated-orcid":false,"given":"Xueyi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona O.","family":"Sarhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-9568-8998","authenticated-orcid":false,"given":"Yazmin B.","family":"Martinez-Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sruti","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madelynn","family":"Shambles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andres","family":"Villabona-Rueda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kadia","family":"Lissit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Tweedie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael T.","family":"Scerba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8734-4118","authenticated-orcid":false,"given":"William R.","family":"Bishai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dmitri","family":"Artemov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9519-9029","authenticated-orcid":false,"given":"Jin-Chong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"D\u2019Alessio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Hafner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3032-1468","authenticated-orcid":false,"given":"Nigel H.","family":"Greig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maura","family":"Manion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0076-0224","authenticated-orcid":false,"given":"Irini","family":"Sereti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9620-7070","authenticated-orcid":false,"given":"Sanjay K.","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,21]]},"reference":[{"key":"75202_CR1","unstructured":"Global tuberculosis report 2025. World Health Organization. (WHO, 2025)."},{"key":"75202_CR2","doi-asserted-by":"publisher","first-page":"e0000069","DOI":"10.1371\/journal.pgph.0000069","volume":"1","author":"PJ Dodd","year":"2021","unstructured":"Dodd, P. J. et al. The global burden of tuberculous meningitis in adults: a modelling study. PLOS Glob. Public Health 1, e0000069 (2021).","journal-title":"PLOS Glob. Public Health"},{"key":"75202_CR3","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofaa257","volume":"7","author":"AM Stadelman","year":"2020","unstructured":"Stadelman, A. M. et al. Treatment outcomes in adult tuberculous meningitis: a systematic review and meta-analysis. Open Forum Infect. Dis. 7, ofaa257 (2020).","journal-title":"Open Forum Infect. Dis."},{"key":"75202_CR4","doi-asserted-by":"publisher","first-page":"3009","DOI":"10.1007\/s00415-019-09523-6","volume":"266","author":"L Wen","year":"2019","unstructured":"Wen, L. et al. Clinical features, outcomes and prognostic factors of tuberculous meningitis in adults worldwide: systematic review and meta-analysis. J. Neurol. 266, 3009\u20133021 (2019).","journal-title":"J. Neurol."},{"key":"75202_CR5","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1186\/s12890-019-0966-8","volume":"19","author":"MG Wang","year":"2019","unstructured":"Wang, M. G. et al. Treatment outcomes of tuberculous meningitis in adults: a systematic review and meta-analysis. BMC Pulm. Med. 19, 200 (2019).","journal-title":"BMC Pulm. Med."},{"key":"75202_CR6","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/nrneurol.2017.120","volume":"13","author":"RJ Wilkinson","year":"2017","unstructured":"Wilkinson, R. J. et al. Tuberculous meningitis. Nat. Rev. Neurol. 13, 581\u2013598 (2017).","journal-title":"Nat. Rev. Neurol."},{"key":"75202_CR7","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/s41590-018-0119-x","volume":"19","author":"SK Jain","year":"2018","unstructured":"Jain, S. K. et al. Tuberculous meningitis: a roadmap for advancing basic and translational research. Nat. Immunol. 19, 521\u2013525 (2018).","journal-title":"Nat. Immunol."},{"key":"75202_CR8","doi-asserted-by":"crossref","unstructured":"Donovan, J. et al. A clinical practice guideline for tuberculous meningitis. Lancet Infect. Dis. 26, e96\u2013e111 (2025).","DOI":"10.1016\/S1473-3099(25)00364-0"},{"key":"75202_CR9","first-page":"13","volume":"67","author":"SJ Shane","year":"1952","unstructured":"Shane, S. J., Clowater, R. A. & Riley, C. The treatment of tuberculous meningitis with cortisone and streptomycin. Can. Med Assoc. J. 67, 13\u201315 (1952).","journal-title":"Can. Med Assoc. J."},{"key":"75202_CR10","first-page":"CD002244","volume":"4","author":"K Prasad","year":"2016","unstructured":"Prasad, K., Singh, M. B. & Ryan, H. Corticosteroids for managing tuberculous meningitis. Cochrane Database Syst. Rev. 4, CD002244 (2016).","journal-title":"Cochrane Database Syst. Rev."},{"key":"75202_CR11","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1056\/NEJMoa2216218","volume":"389","author":"J Donovan","year":"2023","unstructured":"Donovan, J. et al. Adjunctive dexamethasone for tuberculous meningitis in HIV-positive adults. N. Engl. J. Med. 389, 1357\u20131367 (2023).","journal-title":"N. Engl. J. Med."},{"key":"75202_CR12","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S1473-3099(12)70264-5","volume":"13","author":"R Ruslami","year":"2013","unstructured":"Ruslami, R. et al. Intensified regimen containing rifampicin and moxifloxacin for tuberculous meningitis: an open-label, randomised controlled phase 2 trial. Lancet Infect. Dis. 13, 27\u201335 (2013).","journal-title":"Lancet Infect. Dis."},{"key":"75202_CR13","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1093\/cid\/ciac208","volume":"75","author":"MS Paradkar","year":"2022","unstructured":"Paradkar, M. S. et al. Randomized clinical trial of high-dose rifampicin with or without levofloxacin versus standard of care for pediatric tuberculous meningitis: the TBM-KIDS Trial. Clin. Infect. Dis. 75, 1594\u20131601 (2022).","journal-title":"Clin. Infect. Dis."},{"key":"75202_CR14","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.cell.2011.12.023","volume":"148","author":"DM Tobin","year":"2012","unstructured":"Tobin, D. M. et al. Host genotype-specific therapies can optimize the inflammatory response to mycobacterial infections. Cell 148, 434\u2013446 (2012).","journal-title":"Cell"},{"key":"75202_CR15","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1093\/infdis\/jix050","volume":"215","author":"NTT Thuong","year":"2017","unstructured":"Thuong, N. T. T. et al. Leukotriene A4 hydrolase genotype and HIV infection influence intracerebral inflammation and survival from tuberculous meningitis. J. Infect. Dis. 215, 1020\u20131028 (2017).","journal-title":"J. Infect. Dis."},{"key":"75202_CR16","doi-asserted-by":"publisher","first-page":"2434","DOI":"10.1056\/NEJMoa2502866","volume":"393","author":"DB Meya","year":"2025","unstructured":"Meya, D. B. et al. Trial of high-dose oral rifampin in adults with tuberculous meningitis. N. Engl. J. Med. 393, 2434\u20132446 (2025).","journal-title":"N. Engl. J. Med."},{"key":"75202_CR17","doi-asserted-by":"crossref","unstructured":"Donovan, J. et al. Genotype-stratified adjunctive dexamethasone for tuberculous meningitis in HIV-negative adults: a randomized controlled phase 3 trial. Nat. Med. 32, 849\u2013858 (2026).","DOI":"10.1038\/s41591-025-04138-z"},{"key":"75202_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.lansea.2025.100604","volume":"37","author":"R Bhatia","year":"2025","unstructured":"Bhatia, R. et al. A randomised trial to assess the efficacy of add on therapy with aspirin or clopidogrel to the standard medical therapy alone in patients with tubercular meningitis: ACT TBM. Lancet Reg. Health Southeast Asia 37, 100604 (2025).","journal-title":"Lancet Reg. Health Southeast Asia"},{"key":"75202_CR19","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1093\/cid\/ciad401","volume":"77","author":"A Manesh","year":"2023","unstructured":"Manesh, A. et al. Effectiveness of adjunctive high-dose infliximab therapy to improve disability-free survival among patients with severe central nervous system tuberculosis: a matched retrospective cohort study. Clin. Infect. Dis. 77, 1460\u20131467 (2023).","journal-title":"Clin. Infect. Dis."},{"key":"75202_CR20","doi-asserted-by":"publisher","first-page":"e136","DOI":"10.1093\/cid\/ciaa1826","volume":"72","author":"R van Toorn","year":"2021","unstructured":"van Toorn, R., Solomons, R. S., Seddon, J. A. & Schoeman, J. F. Thalidomide use for complicated central nervous system tuberculosis in children: insights from an observational cohort. Clin. Infect. Dis. 72, e136\u2013e145 (2021).","journal-title":"Clin. Infect. Dis."},{"key":"75202_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.tube.2021.102125","volume":"130","author":"R van Toorn","year":"2021","unstructured":"van Toorn, R. et al. The use of thalidomide to treat children with tuberculosis meningitis: a review. Tuberculosis 130, 102125 (2021).","journal-title":"Tuberculosis"},{"key":"75202_CR22","doi-asserted-by":"publisher","first-page":"100871","DOI":"10.1016\/j.eclinm.2021.100871","volume":"35","author":"AG Davis","year":"2021","unstructured":"Davis, A. G. & Wilkinson, R. J. Aspirin in tuberculous meningitis. EClinicalMedicine 35, 100871 (2021).","journal-title":"EClinicalMedicine"},{"key":"75202_CR23","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofaa604","volume":"8","author":"BJ Marais","year":"2021","unstructured":"Marais, B. J. et al. Use of infliximab to treat paradoxical tuberculous meningitis reactions. Open Forum Infect. Dis. 8, ofaa604 (2021).","journal-title":"Open Forum Infect. Dis."},{"key":"75202_CR24","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1136\/sti.2005.017863","volume":"82","author":"C Hardwick","year":"2006","unstructured":"Hardwick, C. et al. Montelukast in the treatment of HIV associated immune reconstitution disease. Sex. Transm. Infect. 82, 513\u2013514 (2006).","journal-title":"Sex. Transm. Infect."},{"key":"75202_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-58190-x","volume":"16","author":"M Singh","year":"2025","unstructured":"Singh, M. et al. Proapoptotic Bcl-2 inhibitor as potential host directed therapy for pulmonary tuberculosis. Nat. Commun. 16, 3003 (2025).","journal-title":"Nat. Commun."},{"key":"75202_CR26","doi-asserted-by":"crossref","unstructured":"Shee, S. et al. Elimination of senescent cells with senolytic host-directed therapy reduces tuberculosis progression in mice. bioRxiv (2025).","DOI":"10.1101\/2025.03.28.645957"},{"key":"75202_CR27","doi-asserted-by":"publisher","first-page":"e1002262","DOI":"10.1371\/journal.ppat.1002262","volume":"7","author":"S Subbian","year":"2011","unstructured":"Subbian, S. et al. Phosphodiesterase-4 inhibition alters gene expression and improves isoniazid-mediated clearance of Mycobacterium tuberculosis in rabbit lungs. PLoS Pathog. 7, e1002262 (2011).","journal-title":"PLoS Pathog."},{"key":"75202_CR28","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/S2213-2600(20)30448-3","volume":"9","author":"RS Wallis","year":"2021","unstructured":"Wallis, R. S. et al. Adjunctive host-directed therapies for pulmonary tuberculosis: a prospective, open-label, phase 2, randomised controlled trial. Lancet Respir. Med. 9, 897\u2013908 (2021).","journal-title":"Lancet Respir. Med."},{"key":"75202_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2024.176600","volume":"973","author":"N Liu","year":"2024","unstructured":"Liu, N. et al. Dabrafenib mitigates the neuroinflammation caused by ferroptosis in experimental autoimmune encephalomyelitis by up regulating Axl receptor. Eur. J. Pharm. 973, 176600 (2024).","journal-title":"Eur. J. Pharm."},{"key":"75202_CR30","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1158\/1078-0432.CCR-23-2094","volume":"30","author":"AD Staniszewska","year":"2024","unstructured":"Staniszewska, A. D. et al. Preclinical characterization of AZD9574, a blood-brain barrier penetrant inhibitor of PARP1. Clin. Cancer Res. 30, 1338\u20131351 (2024).","journal-title":"Clin. Cancer Res."},{"key":"75202_CR31","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1177\/13872877251329439","volume":"105","author":"Y Zhai","year":"2025","unstructured":"Zhai, Y. et al. Semaglutide improves cognitive function and neuroinflammation in APP\/PS1 transgenic mice by activating AMPK and inhibiting TLR4\/NF-kappaB pathway. J. Alzheimers Dis. 105, 416\u2013432 (2025).","journal-title":"J. Alzheimers Dis."},{"key":"75202_CR32","doi-asserted-by":"publisher","first-page":"94","DOI":"10.2174\/156652409787581655","volume":"9","author":"NA Be","year":"2009","unstructured":"Be, N. A., Kim, K. S., Bishai, W. R. & Jain, S. K. Pathogenesis of central nervous system tuberculosis. Curr. Mol. Med 9, 94\u201399 (2009).","journal-title":"Curr. Mol. Med"},{"key":"75202_CR33","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1093\/cid\/ciu641","volume":"59","author":"S Marais","year":"2014","unstructured":"Marais, S. et al. Neutrophil-associated central nervous system inflammation in tuberculous meningitis immune reconstitution inflammatory syndrome. Clin. Infect. Dis. 59, 1638\u20131647 (2014).","journal-title":"Clin. Infect. Dis."},{"key":"75202_CR34","doi-asserted-by":"crossref","unstructured":"Ruiz-Bedoya, C. A. et al. High-dose rifampin improves bactericidal activity without increased intracerebral inflammation in animal models of tuberculous meningitis. J. Clin. Invest. 132, e155851 (2022).","DOI":"10.1172\/JCI155851"},{"key":"75202_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-35730-3","volume":"13","author":"F Mota","year":"2022","unstructured":"Mota, F. et al. Dynamic (18)F-Pretomanid PET imaging in animal models of TB meningitis and human studies. Nat. Commun. 13, 7974 (2022).","journal-title":"Nat. Commun."},{"key":"75202_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-50989-4","volume":"15","author":"X Chen","year":"2024","unstructured":"Chen, X. et al. Dynamic PET reveals compartmentalized brain and lung tissue antibiotic exposures of tuberculosis drugs. Nat. Commun. 15, 6657 (2024).","journal-title":"Nat. Commun."},{"key":"75202_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-018-3633-4","volume":"19","author":"J Soria","year":"2019","unstructured":"Soria, J. et al. Mortality in hospitalized patients with tuberculous meningitis. BMC Infect. Dis. 19, 9 (2019).","journal-title":"BMC Infect. Dis."},{"key":"75202_CR38","doi-asserted-by":"publisher","first-page":"357","DOI":"10.4269\/ajtmh.19-0098","volume":"101","author":"RS Jaipuriar","year":"2019","unstructured":"Jaipuriar, R. S. et al. Early mortality among immunocompetent patients of tuberculous meningitis: a prospective study. Am. J. Trop. Med. Hyg. 101, 357\u2013361 (2019).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"75202_CR39","doi-asserted-by":"crossref","unstructured":"Bhaskar, A. et al. Host sirtuin 2 as an immunotherapeutic target against tuberculosis. Elife 9, e55415 (2020).","DOI":"10.7554\/eLife.55415"},{"key":"75202_CR40","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1056\/NEJMoa040573","volume":"351","author":"GE Thwaites","year":"2004","unstructured":"Thwaites, G. E. et al. Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults. N. Engl. J. Med 351, 1741\u20131751 (2004).","journal-title":"N. Engl. J. Med"},{"key":"75202_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-016-0631-6","volume":"13","author":"JY Wang","year":"2016","unstructured":"Wang, J. Y. et al. Pomalidomide mitigates neuronal loss, neuroinflammation, and behavioral impairments induced by traumatic brain injury in rat. J. Neuroinflammation 13, 168 (2016).","journal-title":"J. Neuroinflammation"},{"key":"75202_CR42","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1530\/jrf.0.0440109","volume":"44","author":"DP Hanlon","year":"1975","unstructured":"Hanlon, D. P., Gale, T. F. & Ferm, V. H. Permeability of the Syrian hamster placenta to manganous ions during early embryogenesis. J. Reprod. Fertil. 44, 109\u2013112 (1975).","journal-title":"J. Reprod. Fertil."},{"key":"75202_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-11-74","volume":"11","author":"M Berk","year":"2013","unstructured":"Berk, M. et al. Aspirin: a review of its neurobiological properties and therapeutic potential for mental illness. BMC Med. 11, 74 (2013).","journal-title":"BMC Med."},{"key":"75202_CR44","doi-asserted-by":"crossref","unstructured":"Michael, J. et al. The leukotriene receptor antagonist montelukast attenuates neuroinflammation and affects cognition in transgenic 5xFAD Mice. Int. J. Mol. Sci. 22, 2782 (2021).","DOI":"10.3390\/ijms22052782"},{"key":"75202_CR45","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.nicl.2014.09.002","volume":"6","author":"AK Heye","year":"2014","unstructured":"Heye, A. K., Culling, R. D., Valdes Hernandez Mdel, C., Thrippleton, M. J. & Wardlaw, J. M. Assessment of blood-brain barrier disruption using dynamic contrast-enhanced MRI. A systematic review. Neuroimage Clin. 6, 262\u2013274 (2014).","journal-title":"Neuroimage Clin."},{"key":"75202_CR46","doi-asserted-by":"publisher","first-page":"e36463","DOI":"10.1097\/MD.0000000000036463","volume":"102","author":"AI Baran","year":"2023","unstructured":"Baran, A. I. et al. Evaluation of cerebrospinal fluid levels for ALOX5, S100B, DEFA1, and GFAP in infectious meningitis. Medicine 102, e36463 (2023).","journal-title":"Medicine"},{"key":"75202_CR47","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1093\/cid\/cix540","volume":"65","author":"UK Rohlwink","year":"2017","unstructured":"Rohlwink, U. K. et al. Biomarkers of cerebral injury and inflammation in pediatric tuberculous meningitis. Clin. Infect. Dis. 65, 1298\u20131307 (2017).","journal-title":"Clin. Infect. Dis."},{"key":"75202_CR48","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.ijantimicag.2014.12.027","volume":"45","author":"L Te Brake","year":"2015","unstructured":"Te Brake, L. et al. Pharmacokinetic\/pharmacodynamic analysis of an intensified regimen containing rifampicin and moxifloxacin for tuberculous meningitis. Int. J. Antimicrob. Agents 45, 496\u2013503 (2015).","journal-title":"Int. J. Antimicrob. Agents"},{"key":"75202_CR49","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1056\/NEJMoa1507062","volume":"374","author":"AD Heemskerk","year":"2016","unstructured":"Heemskerk, A. D. et al. Intensified antituberculosis therapy in adults with tuberculous meningitis. N. Engl. J. Med. 374, 124\u2013134 (2016).","journal-title":"N. Engl. J. Med."},{"key":"75202_CR50","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1038\/s41580-020-0259-3","volume":"21","author":"J Kim","year":"2020","unstructured":"Kim, J., Koo, B. K. & Knoblich, J. A. Human organoids: model systems for human biology and medicine. Nat. Rev. Mol. Cell Biol. 21, 571\u2013584 (2020).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"75202_CR51","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.trsl.2022.06.013","volume":"250","author":"TT Priyathilaka","year":"2022","unstructured":"Priyathilaka, T. T., Laaker, C. J., Herbath, M., Fabry, Z. & Sandor, M. Modeling infectious diseases of the central nervous system with human brain organoids. Transl. Res 250, 18\u201335 (2022).","journal-title":"Transl. Res"},{"key":"75202_CR52","unstructured":"Catalizing the Development and Use of Novel Alternative Methods. Advisory Committee to the Director, National Institutes of Health. (2023)."},{"key":"75202_CR53","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1007\/s00280-003-0722-9","volume":"53","author":"AE Bolton","year":"2004","unstructured":"Bolton, A. E. et al. Effect of rifampicin on the pharmacokinetics of imatinib mesylate (Gleevec, STI571) in healthy subjects. Cancer Chemother. Pharm. 53, 102\u2013106 (2004).","journal-title":"Cancer Chemother. Pharm."},{"key":"75202_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-43937-1","volume":"14","author":"S Krug","year":"2023","unstructured":"Krug, S. et al. Inhibition of host PARP1 contributes to the anti-inflammatory and antitubercular activity of pyrazinamide. Nat. Commun. 14, 8161 (2023).","journal-title":"Nat. Commun."},{"key":"75202_CR55","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1177\/088307380401900402","volume":"19","author":"JF Schoeman","year":"2004","unstructured":"Schoeman, J. F. et al. Adjunctive thalidomide therapy for childhood tuberculous meningitis: results of a randomized study. J. Child Neurol. 19, 250\u2013257 (2004).","journal-title":"J. Child Neurol."},{"key":"75202_CR56","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1002\/j.1460-2075.1985.tb03725.x","volume":"4","author":"D Aslanian","year":"1985","unstructured":"Aslanian, D. & Negrerie, M. A Raman spectroscopic investigation of the lipid state in acetylcholine receptor-rich membranes from Torpedo marmorata. EMBO J. 4, 965\u2013969 (1985).","journal-title":"EMBO J."},{"key":"75202_CR57","doi-asserted-by":"crossref","unstructured":"Mai, N. T. H. et al. A randomised double blind placebo controlled phase 2 trial of adjunctive aspirin for tuberculous meningitis in HIV-uninfected adults. Elife 7, e33478 (2018).","DOI":"10.7554\/eLife.33478"},{"key":"75202_CR58","doi-asserted-by":"crossref","unstructured":"Calderin, J. M. et al. Pharmacokinetics of dexamethasone in tuberculous meningitis. Clin. Infect Dis. 82, e1036\u2013e1042 (2025).","DOI":"10.1093\/cid\/ciaf642"},{"key":"75202_CR59","doi-asserted-by":"crossref","unstructured":"Chen, X. et al. Beyond Rifampin: evaluating rifapentine and rifabutin as alternative treatments for TB meningitis. J. Infect Dis. jiag087 (2026).","DOI":"10.1093\/infdis\/jiag087"},{"key":"75202_CR60","doi-asserted-by":"crossref","unstructured":"Fang, H. et al. APOE genotype confers context-dependent neurovascular vulnerability in immune-vascularized human forebrain organoids. bioRxiv (2025).","DOI":"10.1101\/2025.05.08.652864"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-75202-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-75202-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-75202-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T09:03:36Z","timestamp":1784624616000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-75202-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,21]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["75202"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-75202-6","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,21]]},"assertion":[{"value":"27 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"6178"}}